Put the exact product beside the claim.
Write down the full name of the proposed medicine. Beside the name, write how you would take it, such as a tablet or an injection. Then ask what health problem the claim addresses.
The Food and Drug Administration (FDA) reviews a specific product for a particular use.
A broad word such as “peptide” cannot do that checking for you.
Check what the record can establish.
Ask which record answers the claim. Different records answer different questions.
A product approval record
Use it to check the named medicine and the use that was reviewed. Ask where to find the full product record.
A doctor’s licence record
A state medical board records the current status of a doctor’s licence and any action the board has taken against that doctor.
Use that record to check the doctor’s permission to practise. Ask for a medicine’s approval record or a study when checking a claim about the medicine.
An FDA registration or medicine code
FDA registration means a business is entered in the FDA’s records. As of September 2026, that registration does not show that FDA approved the medicine.
The National Drug Code (NDC) identifies a medicine by number in the FDA’s drug list.
An NDC alone cannot establish FDA approval, as of September 2026.
Keep the limits in view.
Thymosin alpha-1, also called thymalfasin, is a peptide ingredient.
As of September 2026, no US medicine containing it has FDA approval.
This guide has no verified answer about what it would treat for you. Ask which health problem it is being offered for and what studies support that use.
People or groups asked FDA to allow thymosin alpha-1 in medicines made to order. They later took back their requests. The FDA page is current as of April 22, 2026, and marks these requests “withdrawn”.
As of September 2026, taking back the request gave pharmacies no permission to make medicine with it.
FDA has not clearly explained the legal effect of taking back these requests, as of September 2026.
FDA still lists safety concerns beside thymosin alpha-1 on that page.
For injected peptide ingredients, FDA describes worries about the body reacting to them and about impurities in the medicine.
Ask what those concerns mean for you and how the pharmacy checks what is in the medicine. Ask which current rule allows the pharmacy to make your exact medicine. If that is unclear, ask your state’s pharmacy board before agreeing.
As of September 2026, FDA does not review compounded medicines before sale for safety, quality or how well the medicines work.
Ask what a study or report really answers.
If a study is offered as proof, ask for its title and source. Ask whether it examined the same product and the same reason for treatment.
Ask what the study found in people, what it did not answer and whether the proposed care matches it. Ask your treating clinician, whether a doctor or another health professional, to explain the result in everyday words.
A number without an explanation is hard to use. Keep a note of the answer, then ask what decision it helps you make.
A report about a medicine problem is not proof that the medicine was its cause.
FDA says those reports cannot be used to work out how often a problem occurs.
Read the source
Open the original record
- FDA: ingredient concerns and request status
Find the proposed ingredient. Read its whole entry, including the concern beside its name.
- FDA: what a drug code establishes
Read the explanation of a directory listing before treating a code as evidence.
- FDA: limits of problem reports
The notes explain why a report alone cannot show cause or tell you how common a problem is.